While the physicians at Carolina Total Wellness are thrilled that the use of hormone replacement therapy (HRT) in menopause has gained acceptance in conventional medicine and social media conversations, there is one area that is still causing some confusion.

If you are taking or considering taking HRT you may hear two similar-sounding words: progesterone and progestin. They are not the same—and the difference can matter for your long-term safety.

Progesterone is the natural hormone your ovaries made before menopause. The form used in many modern regimens is micronized progesterone—chemically identical to your body’s own hormone. You may hear micronized progesterone described as bio-identical progesterone.

Progestins are synthetic (lab-made) compounds designed to mimic some of progesterone’s effects. Common examples include medroxyprogesterone acetate (MPA), the progestin used in the large Women’s Health Initiative (WHI) trials.

Both can protect the uterine lining when you take estrogen (important if you still have a uterus). At appropriate doses, natural progesterone and synthetic progestins appear similarly effective at preventing endometrial hyperplasia. [1]

The WHI showed that conjugated estrogen plus the synthetic progestin MPA raised breast cancer incidence, while estrogen alone (in women without a uterus) did not and was linked to lower breast cancer rates over long-term follow-up. [2]

Later research comparing formulations suggests the progestogen type is a key factor. Observational data and reviews indicate that estrogen combined with micronized progesterone is associated with a lower breast cancer risk than estrogen plus synthetic progestins. [3][4] One meta-analysis found roughly one-third lower relative breast cancer risk with progesterone versus synthetic progestins when each was paired with estrogen. [4]

Reviews also point to a similar or possibly more favorable profile for cardiovascular and metabolic outcomes with micronized progesterone compared with many synthetic progestins. [1][5][6] Natural progesterone is the preferred choice when breast or cardiovascular risk factors are a concern. [7][6]

What This Means for You

Hormone therapy remains the most effective treatment for bothersome vasomotor symptoms and can support bone, brain, cardiovascular and genitourinary health when started in appropriate candidates. [8][9] If you have a uterus, a progestogen is required with systemic estrogen.

Choosing micronized progesterone (often taken orally at bedtime) is one practical way many clinicians individualize therapy toward a potentially better breast and overall safety profile while still protecting the endometrium. Transdermal estradiol plus oral micronized progesterone is a common evidence-aligned combination.

Therapy should always be personalized—dose, route, timing, and your personal risk factors. If you are interested in HRT or have questions about your current HRT therapy, the physicians at Carolina Total Wellness can help.